You are here

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood

Authors

  • Soudabeh Rad Pour Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Yago Pico de Coaña Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Xavier Martinez Demorentin Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain PubMed articlesGoogle scholar articles
  • Jeroen Melief Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Manjula Thimma Biological and Environmental Sciences and Engineering Division (BESE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia PubMed articlesGoogle scholar articles
  • Maria Wolodarski Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenKarolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • David Gomez-Cabrero Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Stockholm, SwedenNavarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, SpainBiological and Environmental Sciences and Engineering Division (BESE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia PubMed articlesGoogle scholar articles
  • Johan Hansson Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenKarolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Rolf Kiessling Department of Oncology-Pathology, Karolinska Institutet, Stockholm, SwedenKarolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Jesper Tegner Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Stockholm, SwedenBiological and Environmental Sciences and Engineering Division (BESE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi ArabiaComputer, Electrical, and Mathematical Sciences and Engineering Division (CEMSE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Soudabeh Rad Pour; soudabeh.radp{at}yahoo.com; Professor Jesper Tegner; Jesper.tegner{at}kaust.edu.sa
View Full Text

Citation

Rad Pour S, Pico de Coaña Y, Demorentin XM, et al
Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood
Journal for ImmunoTherapy of Cancer 2021;9:e002171. doi: 10.1136/jitc-2020-002171

Publication history

  • Accepted March 23, 2021
  • First published May 7, 2021.
Online issue publication 
February 07, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.